Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 44

1.

Gray Zone Lymphoma: Current Diagnosis and Treatment Options.

Pilichowska M, Kritharis A, Evens AM.

Hematol Oncol Clin North Am. 2016 Dec;30(6):1251-1260. doi: 10.1016/j.hoc.2016.07.006. Review.

PMID:
27888879
2.

A case of composite classical and nodular lymphocyte predominant Hodgkin lymphoma with progression to diffuse large B-cell non-Hodgkin lymphoma: Diagnostic difficulty in fine-needle aspiration cytology.

Das DK, Sheikh ZA, Al-Shama'a MH, John B, Alawi AM, Junaid TA.

Diagn Cytopathol. 2016 Nov 26. doi: 10.1002/dc.23643. [Epub ahead of print]

PMID:
27888658
3.

Mediastinal Gray Zone Lymphoma with Features Intermediate between Classical Hodgkin Lymphoma and Primary Mediastinal B-Cell Lymphoma.

Song HN, Kim SJ, Ko YH, Kim WS.

Acta Haematol. 2016;136(3):186-90. doi: 10.1159/000448159.

PMID:
27623181
4.

B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Burkitt's lymphoma: A case report and review.

Chettiankandy TJ, Tupkari JV, Kumar K, Ahire MS.

J Oral Maxillofac Pathol. 2016 May-Aug;20(2):333. doi: 10.4103/0973-029X.185936.

5.

[Mediastinal gray zone lymphoma: a case report and literature review].

Zhu JF, Gao GY, Zeng WQ, Li Q, Wu ZD, Xu W, Li JY.

Zhonghua Xue Ye Xue Za Zhi. 2016 Jun 14;37(6):532-4. doi: 10.3760/cma.j.issn.0253-2727.2016.06.020. Chinese. No abstract available.

PMID:
27431084
6.

The immunophenotypic spectrum of primary mediastinal large B-cell lymphoma reveals prognostic biomarkers associated with outcome.

Bledsoe JR, Redd RA, Hasserjian RP, Soumerai JD, Nishino HT, Boyer DF, Ferry JA, Zukerberg LR, Harris NL, Abramson JS, Sohani AR.

Am J Hematol. 2016 Oct;91(10):E436-41. doi: 10.1002/ajh.24485.

PMID:
27419920
7.

Dose adjusted-EPOCH-R and mediastinal disease may improve outcomes for patients with gray-zone lymphoma.

Chihara D, Westin JR, Miranda RN, Cheah CY, Oki Y, Turturro F, Romaguera JE, Neelapu SS, Nastoupil LJ, Fayad LE, Rodriguez MA, Fowler NH, Orlowski RZ, Wang M, Hagemeister FB, Medeiros LJ, Fanale MA.

Br J Haematol. 2016 Jul 5. doi: 10.1111/bjh.14226. [Epub ahead of print] No abstract available.

PMID:
27378601
8.

Recurrent mutations of the exportin 1 gene (XPO1) and their impact on selective inhibitor of nuclear export compounds sensitivity in primary mediastinal B-cell lymphoma.

Jardin F, Pujals A, Pelletier L, Bohers E, Camus V, Mareschal S, Dubois S, Sola B, Ochmann M, Lemonnier F, Viailly PJ, Bertrand P, Maingonnat C, Traverse-Glehen A, Gaulard P, Damotte D, Delarue R, Haioun C, Argueta C, Landesman Y, Salles G, Jais JP, Figeac M, Copie-Bergman C, Molina TJ, Picquenot JM, Cornic M, Fest T, Milpied N, Lemasle E, Stamatoullas A, Moeller P, Dyer MJ, Sundstrom C, Bastard C, Tilly H, Leroy K.

Am J Hematol. 2016 Sep;91(9):923-30. doi: 10.1002/ajh.24451.

PMID:
27312795
9.

How I manage patients with grey zone lymphoma.

Kritharis A, Pilichowska M, Evens AM.

Br J Haematol. 2016 Aug;174(3):345-50. doi: 10.1111/bjh.14174. Review.

PMID:
27301470
10.

Mediastinal Gray Zone Lymphoma.

Bhardwaj M, Saha R, Misra DS, Malhotra V.

Indian J Chest Dis Allied Sci. 2015 Oct-Dec;57(4):255-7.

PMID:
27164737
11.

EBV-positive diffuse large B-cell lymphoma of the elderly: 2016 update on diagnosis, risk-stratification, and management.

Castillo JJ, Beltran BE, Miranda RN, Young KH, Chavez JC, Sotomayor EM.

Am J Hematol. 2016 May;91(5):529-37. doi: 10.1002/ajh.24370. Review.

PMID:
27093913
12.

Mediastinal Gray Zone Lymphoma: A Wider Category Than We Think?

Verma A, Shet T, Epari S, Gupta M, Gujral S, Khanna N, Laskar S, Sengar M, Arora B, Menon H, Banavali S.

Int J Surg Pathol. 2016 Aug;24(5):382-93. doi: 10.1177/1066896916635816.

PMID:
26957476
13.

The t(14;18)(q32;q21) with extra MYC signal - is it a gray zone lymphoma?

Chang QA, Qasem A, Madhusudhana S, Glazyrin A.

Int J Clin Exp Pathol. 2015 Aug 1;8(8):9602-8.

14.

Distinguishing Classical Hodgkin Lymphoma, Gray Zone Lymphoma, and Large B-cell Lymphoma: A Proposed Scoring System.

O'Malley DP, Fedoriw Y, Weiss LM.

Appl Immunohistochem Mol Morphol. 2016 Sep;24(8):535-40. doi: 10.1097/PAI.0000000000000236.

PMID:
26447896
15.

B Cell Lymphoma, Unclassifiable, Transformed from Follicular Lymphoma: A Rare Presentation with Review of the Literature.

Kanna A, Agrawal S, Jayant K, Kumar Pala V, Altujjar M, Hadid T, Khurram M.

Case Rep Hematol. 2015;2015:651764. doi: 10.1155/2015/651764.

16.

Identification of Primary Mediastinal Large B-cell Lymphoma at Nonmediastinal Sites by Gene Expression Profiling.

Yuan J, Wright G, Rosenwald A, Steidl C, Gascoyne RD, Connors JM, Mottok A, Weisenburger DD, Greiner TC, Fu K, Smith L, Rimsza LM, Jaffe ES, Campo E, Martinez A, Delabie J, Braziel RM, Cook JR, Ott G, Vose JM, Staudt LM, Chan WC; Lymphoma Leukemia Molecular Profiling Project (LLMPP)..

Am J Surg Pathol. 2015 Oct;39(10):1322-30. doi: 10.1097/PAS.0000000000000473.

PMID:
26135560
17.

Gray zone lymphoma with features intermediate between classical Hodgkin lymphoma and diffuse large B-cell lymphoma: characteristics, outcomes, and prognostication among a large multicenter cohort.

Evens AM, Kanakry JA, Sehn LH, Kritharis A, Feldman T, Kroll A, Gascoyne RD, Abramson JS, Petrich AM, Hernandez-Ilizaliturri FJ, Al-Mansour Z, Adeimy C, Hemminger J, Bartlett NL, Mato A, Caimi PF, Advani RH, Klein AK, Nabhan C, Smith SM, Fabregas JC, Lossos IS, Press OW, Fenske TS, Friedberg JW, Vose JM, Blum KA.

Am J Hematol. 2015 Sep;90(9):778-83. doi: 10.1002/ajh.24082.

18.

EBV-positive large B-cell lymphomas in young patients: a nodal lymphoma with evidence for a tolerogenic immune environment.

Nicolae A, Pittaluga S, Abdullah S, Steinberg SM, Pham TA, Davies-Hill T, Xi L, Raffeld M, Jaffe ES.

Blood. 2015 Aug 13;126(7):863-72. doi: 10.1182/blood-2015-02-630632.

19.

Primary mediastinal B-cell lymphoma and mediastinal gray zone lymphoma: do they require a unique therapeutic approach?

Dunleavy K, Wilson WH.

Blood. 2015 Jan 1;125(1):33-9. doi: 10.1182/blood-2014-05-575092. Review.

20.

Aggressive B-cell lymphomas with translocations involving BCL6 and MYC have distinct clinical-pathologic characteristics.

Turakhia SK, Hill BT, Dufresne SD, Nakashima MO, Cotta CV.

Am J Clin Pathol. 2014 Sep;142(3):339-46. doi: 10.1309/AJCPBWVHTF7RRSA4.

Items per page

Supplemental Content

Loading ...
Support Center